Evidence map›Paper›PMID 35775319›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2022

Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials.

Anju T Peters, Zachary M Soler, Robert C Kern, Enrico Heffler, Jorge F Maspero, Louis Crampette, Shigeharu Fujieda, Andrew P Lane, Haixin Zhang, Scott Nash and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Practical recommendations for managing severe chronic rhinosinusitis with nasal polyps in the era of biologics.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anju T PetersAllergy-Immunology Division and the Sinus and Allergy Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Zachary M SolerDepartment of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Robert C KernDepartment of Otolaryngology - Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Enrico HefflerPersonalized Medicine, Asthma & Allergy - Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy.
Jorge F MasperoAllergy and Respiratory Medicine, Fundación CIDEA, Buenos Aires, Argentina.
Louis CrampetteDepartment of Otorhinolaryngology - Head and Neck Surgery and Maxillofacial Surgery, University Hospital of Montpellier, Montpellier, France.
Shigeharu FujiedaDepartment of Otorhinolaryngology - Head/Neck Surgery, University of Fukui, Fukui, Japan.
Andrew P LaneDepartment of Otolaryngology - Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Haixin ZhangMedical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Scott NashMedical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Asif H KhanGlobal Medical Affairs, Sanofi, Chilly-Mazarin, France.
Shahid SiddiquiMedical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Juby A Jacob-NaraGlobal Medical Affairs, Sanofi, Bridgewater, New Jersey, USA.
Paul RoweGlobal Medical Affairs, Sanofi, Bridgewater, New Jersey, USA.
Yamo DenizMedical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Nasal PolypsRhinitisSinusitisAntibodies, Monoclonal, HumanizedChronic DiseaseHumansPatient Reported Outcome MeasuresQuality of LifeSmellAntibodies, Monoclonal, Humanizeddupilumab

Identifiers

PMID35775319
PMCPMC9545952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.